Cross-ancestry GWAS of more than 1.8 million people flags SERPINA1, SMAD3, and other bronchiectasis targets shared with COPD and chronic bronchitis.
|Articles|January 1, 1998
Supplements and Featured Publications
- A Managed Care Appraisal of Atypical Agents in the Treatment of Psychoses
- Volume 4
- Issue 1 Suppl
Chronic Ambulatory Outpatients and Four-Vector Management
Author(s)Richard Petty, MD
Advertisement
Articles in this issue
almost 29 years ago
Common Treatment Goals: Switching Antipsychoticsalmost 29 years ago
Antipsychotics : Present and Futurealmost 29 years ago
Atypical Antipsychotics in the Managed Care Eraalmost 29 years ago
CME Quizalmost 29 years ago
Selected Abstractsalmost 29 years ago
Bibliographyalmost 29 years ago
Participating Facultyalmost 29 years ago
Introduction - The Routine Use of Atypical Antipsychoticsalmost 29 years ago
Atypical Antipsychotics and Formulary DecisionsAdvertisement
Related to this article
The FDA approved bepirovirsen, the first antisense oligonucleotide for chronic hepatitis B, offering a new treatment with functional cure potential.
ALIS added to azithromycin and ethambutol raised culture conversion in new MAC lung disease, with rare resistance, in an ENCORE analysis at IDWeek 2026.
A real-world trial found 42.6% of patients with severe hand eczema cleared on oral alitretinoin.
AMCP Nexus 2026 brings managed care leaders to San Diego October 26-29 to tackle Medicare negotiation, drug pricing policy, AI, and patient access.
IDWeek 2026 posters describe a rule-based tool classifying about 1 in 5 patients with cUTI as outpatient-eligible and 5 clusters with varied LOS.
Insmed’s once-daily TPIP prodrug shows sustained lung vasodilation in PAH and PH-ILD, improving walk distance and other key measures.
An international eDelphi panel of 62 dermatologists agreed on a 2-step algorithm for tapering psoriasis biologics.
Advertisement
Advertisement
Trending on AJMC
1
Awareness Gaps Drive Narcolepsy, IH Delays: Logan Schneider, MD
2
Extension Studies in TPIP Show Promise in PAH, PH-ILD
3
International Panel Agrees on Framework for Tapering Psoriasis Biologics
4
Bepirovirsen Approval Offers New Option for Chronic HBV Treatment
5